Bioinformatics

Bioinformatics is at the cutting edge of modern life sciences, driving innovation across diagnostics, therapeutics, and personalised medicine. By harnessing biological data and applying computational tools, researchers are uncovering new insights into disease, developing in silico drug discovery platforms, and predicting patient outcomes with unprecedented precision.

Protecting these innovations requires a sophisticated intellectual property strategy that understands both biological complexity and software-driven processes. HGF has a long-standing reputation for IP excellence in life sciences and data-centric technologies, making us ideally placed to support bioinformatics innovators.

Our expertise includes:

  • AI and machine learning models trained on biological data
  • Genomic analysis and personalised medicine platforms
  • Computational biology tools and software pipelines
  • Data integration, visualisation, and analytics systems
  • Expert guidance on patentability of algorithms, databases and diagnostic methods under European patent law
  • Coordinating parallel patent strategies across EP, national and international filing routes

From spinouts leveraging university research to global pharmaceutical companies developing next-generation therapies, we work with a broad range of clients to protect core technologies and support commercial success.

We understand the particular challenges of patenting bioinformatics inventions, from hybrid software/biotech technologies to patentability requirements in software and AI innovations. Our attorneys provide commercially focused IP strategies that align with your R&D roadmap, regulatory environment, and funding goals.

Our integrated approach draws on a wealth of technical and legal knowledge across disciplines, combining life sciences, software, and medical regulation expertise. We offer a full suite of IP protection tools, including patents, trade secrets, copyright, and database rights.

At HGF, we don’t just file patents, we help shape your competitive advantage in a fast-evolving market. Partner with us for IP strategies that secure your position at the forefront of bioinformatics innovation.

Latest updates

Event - 24th - 25th November 2025

HGF Partners with 3AF for the P2I2025 Symposium

HGF are pleased to be a partner of P2I2025, the annual symposium organised by the Intellectual Property Commission of the French Aeronautics and Astronautics Association (3AF). The event brings together …

Event details
Event - 12th September 2025

Wolters Kluwer Breakfast Panel on AI & IP at AIPPI

Sofie McPherson, Patent Director at HGF, will be moderating a special breakfast panel session hosted by Wolters Kluwer at the AIPPI World Congress in Yokohama on 15 September 2025. Session …

Event details

Welcome to HGF Presents - New Video Series

Introducing HGF Presents a new video series delivering practical insights into European Patent Law and practice. Curated by our leading experts in chemistry, life sciences, technology & engineering, each concise …

Read article

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

HGF Sets the Gold Standard – Recognised for 7th Year in a Row by Financial Times

We are extremely honoured to announce that HGF has once again been ranked ‘Gold’ across all six bands in the Financial Times Special Report – Europe’s Leading Patent Law Firms …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article

Can intellectual property and foreign investment save struggling European eVTOL companies?

With the ongoing funding difficulties in the European eVTOL sector, we look at the role that intellectual property is likely to play in the prospects for the survival of Lilium …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our bioinformatics specialists.